<SEC-DOCUMENT>0001104659-19-043766-index.html : 20190802
<SEC-HEADER>0001104659-19-043766.hdr.sgml : 20190802
<ACCEPTANCE-DATETIME>20190802172323
ACCESSION NUMBER:		0001104659-19-043766
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190802
DATE AS OF CHANGE:		20190802

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gemphire Therapeutics Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89598
		FILM NUMBER:		19996969

	BUSINESS ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
		BUSINESS PHONE:		248-980-6538

	MAIL ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bisgaier Charles PhD
		CENTRAL INDEX KEY:			0001381030

	FILING VALUES:
		FORM TYPE:		SC 13D

	MAIL ADDRESS:	
		STREET 1:		17199 N. LAUREL PARK DRIVE
		STREET 2:		SUITE 401
		CITY:			LIVONIA
		STATE:			MI
		ZIP:			48152
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>a19-16501_1sc13d.htm
<DESCRIPTION>SC 13D
<TEXT>
Document 1 - file: a19-16501_1sc13d.htm

</DOCUMENT>
</SEC-DOCUMENT>